Hangzhou China Resources Laotongjun Pharmaceutical Co., Ltd. · 66-41 · CHINA
For Hangzhou China Resources Laotongjun Pharmaceutical Co., Ltd. · 66-41 · CHINA, import alert is 66-41; import alert name is Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S; country is CHINA; product is Kangbingdu (Antiviral Oral Solution) | Kangbingdu (Antiviral Oral Solution) | Kangbingdu (Antiviral Oral Solution) | Kangbingdu (Antiviral Oral Solution); product code is 54 F - - 99 Herbals & Botanicals (not Teas), N.E.C. | 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. | 58 E - - 99 Antiviral, NEC | 66 V - - 99 Miscellaneous Patent Medicines, Etc; date published is 06/04/2024; address is No. 88 Langyuan Road , Tonglu Economic Development Zone , Hangzhou, Cn-Zj CHINA, verified against its source on 2026-09-16.
- Firm
- Hangzhou China Resources Laotongjun Pharmaceutical Co., Ltd. verified
- Import alert
- 66-41
- Import alert name
- Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S.
- Country
- CHINA verified
- Address
- No. 88 Langyuan Road , Tonglu Economic Development Zone , Hangzhou, Cn-Zj CHINA verified
- Date published
- 06/04/2024 verified
- Product code
- 54 F - - 99 Herbals & Botanicals (not Teas), N.E.C. | 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. | 58 E - - 99 Antiviral, NEC | 66 V - - 99 Miscellaneous Patent Medicines, Etc. each item verified
- Product
- Kangbingdu (Antiviral Oral Solution) | Kangbingdu (Antiviral Oral Solution) | Kangbingdu (Antiviral Oral Solution) | Kangbingdu (Antiviral Oral Solution) each item verified
- FDA notes
- The product appears to be a new drug within the meaning of Section 201(p) of the Act, without an effective new drug application (NDA) [Unapproved New Drug, Section 505(a)], as its labeling includes claims such as: “Anti-viral oral solution” and “Is used for… cold, and influenza”. | The product appears to be a new drug within the meaning of Section 201(p) of the Act, without an effective new drug application (NDA) [Unapproved New Drug, Section 505(a)], as its labeling includes claims such as: “Anti-viral oral solution” and “Is used for… cold, and influenza”. | The product appears to be a new drug within the meaning of Section 201(p) of the Act, without an effective new drug application (NDA) [Unapproved New Drug, Section 505(a)], as its labeling includes claims such as: “Anti-viral oral solution” and “Is used for… cold, and influenza”. | The product appears to be a new drug within the meaning of Section 201(p) of the Act, without an effective new drug application (NDA) [Unapproved New Drug, Section 505(a)], as its labeling includes claims such as: “Anti-viral oral solution” and “Is used for… cold, and influenza”. each item verified
What the source says
Hangzhou China Resources Laotongjun Pharmaceutical Co., Ltd. Date Published : 06/04/2024 No. 88 Langyuan Road , Tonglu Economic Development Zone , Hangzhou, Cn-Zj CHINA 54 F - - 99 Herbals & Botanicals (not Teas), N.E.C. Date Published: 06/04/2024 Desc: Kangbingdu (Antiviral Oral Solution) Notes: The product appears to be a new drug within the meaning of Section 201(p) of the Act, without an effective new drug application (NDA) [Unapproved New Drug, Section 505(a)], as its labeling includes claims such as: “Anti-viral oral solution” and “Is used for… cold, and influenza”. 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. Date Published: 06/04/2024 Desc: Kangbingdu (Antiviral Oral Solution) Notes: The product appears to be a new drug within the meaning of Section 201(p) of the Act, without an effective new drug application (NDA) [Unapproved New Drug, Section 505(a)], as its labeling includes claims such as: “Anti-viral oral solution” and “Is used for… cold, and influenza”. 58 E - - 99 Antiviral, NEC Date Published: 06/04/2024 Desc: Kangbingdu (Antiviral Oral Solution) Notes: The product appears to be a new drug within the meaning of Section 201(p) of the Act, without an effective new drug application (NDA) [Unapproved New Drug, Section 505(a)], as its labeling includes claims such as: “Anti-viral oral solution” and “Is used for… cold, and influenza”. 66 V - - 99 Miscellaneous Patent Medicines, Etc. Date Published: 06/04/2024 Desc: Kangbingdu (Antiviral Oral Solution) Notes: The product appears to be a new drug within the meaning of Section 201(p) of the Act, without an effective new drug application (NDA) [Unapproved New Drug, Section 505(a)], as its labeling includes claims such as: “Anti-viral oral solution” and “Is used for… cold, and influenza”.
— accessdata.fda.gov, retrieved 2026-09-15
Source
- accessdata.fda.govhttps://www.accessdata.fda.gov/cms_ia/importalert_190.html
This one changes, and we watch it.FDA import alert red lists: firms subject to detention without physical examination is re-read on a schedule and every change is dated. Subscribe: Atom feed · JSON · what has changed so far.